The cytokines tumor necrosis factor (TNF), beta interferon (IFN-P), and IFN-y increase major (35, 52) . TNF in combination with either type of IFN induces a greater than additive (i.e., synergistic) HLA class I surface and mRNA expression in endothelial cells (33), which results from the synergistic transcriptional activation of the structural HLA class I heavy-and light-chain genes by . The molecular basis of synergy is the subject of the present investigation.
Major histocompatibility complex (MHC) class I molecules, called HLA-A, -B, and -C in humans, bind peptides derived from endogenously synthesized proteins, thereby forming a structure on the cell surface that is recognized by specific cytotoxic T lymphocytes (CTL). Class I-restricted CTL specific for viral or intracellular bacterial proteins constitute a major line of host defense against such infections (1) . Nearly all cells synthesize and express class I molecules constitutively, and both synthesis and expression are strongly increased by the inflammatory cytokines tumor necrosis factor (TNF), beta interferon (IFN-,), and IFN-y. Inducible MHC molecule synthesis at sites of infection is likely to be important because the ability of a cell to be recognized by CTL is a function of the rate of class I molecule synthesis and not the absolute level of class I molecule expression (10) . This functional observation is consistent with the biochemical evidence that peptides bind to MHC class I molecules only during the folding and assembly of nascent class I heavy and light chains (B2-microglobulin) in the endoplasmic reticulum (35, 52) . TNF in combination with either type of IFN induces a greater than additive (i.e., synergistic) HLA class I surface and mRNA expression in endothelial cells (33) , which results from the synergistic transcriptional activation of the structural HLA class I heavy-and light-chain genes by TNF and IFN--y (29) . The molecular basis of synergy is the subject of the present investigation.
Cytokine-regulated transcription of many genes, including MHC genes, is mediated by the binding of proteins to DNA sequences located in the gene, often in the promoter region 5' of the CAAT and TATA boxes (28) . Sequences regulating transcription have been identified by measuring the response of transfected mutant genes, and several of the proteins binding these sequences have been characterized. The transcriptional response to TNF is mediated by two different DNA-binding factors, NF-KB and AP-1. TNF induces transcription of human immunodeficiency virus type 1 by activating NF-KB (15) , perhaps by causing its dissociation from IKB, with which it constitutes a latent complex in the cytoplasm of nonlymphoid cells (19) . Upon dissociation, free NF-KB moves to the nucleus, where it binds to the KB consensus sequence GGGRHTYYCC (34) . TNF also induces the transcription of the genes encoding two principal subunits, c-Jun and c-Fos, of the transcription factor AP-1, which binds to the consensus sequence GTGAGTMA (5) . Both the KB and AP-1 consensus sequences (when multimerized) can confer TNF responsiveness upon heterologous promoters (5, 28) . Both elements are found in the HLA-B promoter (29) . Repeated, degenerate NF-KB elements are present in the promoter of a murine MHC class I gene, H-2K', and have been implicated in the TNF response of this gene (28) . However, only a single such element is clearly present in the human MHC class I gene promoter, and a single copy of the mouse KB element was not sufficient to mediate TNF-induced transcriptional activation (28) .
The promoters of several IFN-a-responsive genes, including HLA-A2, were compared to determine the original, large (29-bp) interferon consensus sequence (ICS) (16) . Subsequent studies have produced shorter consensus sequences, AGT1TTCNNYTYY (48) and AGTITC(N)NTITCC (42) .
IFN AND TNF SYNERGY ON HLA CLASS I
IFN-a rapidly activates the transcription factor ISGF3 (44) . Since IFN-a and IFN-P, called type I IFNs, bind to a common receptor (47) , it is widely thought that the ICS also mediates the response to IFN-P. IFN--y, called type II IFN, uses a distinct receptor (47) and slowly induces the synthesis of the ICS-binding transcription factor ISGF2 (17) . A fragment of the HLA-B gene promoter that includes an ICS (.. .TCACT l... .) mediates the response to both IFN-a and IFN--y (23) . A novel IFN-responsive element, called the IFN--y activation site, has been recently described (11) , but no homologous site has been identified in the HLA class I promoters. A second, canonical ICS located further upstream in the HLA-A2 promoter has been identified (2) , and additional IFN-responsive enhancers have been mapped within the body of the HLA-B7 gene (18, 53) , but their contribution to the IFN response of these genes has not been established.
The human MHC heavy-chain genes, HLA-A, -B, and -C, differ in their levels of constitutive expression in different tissues and in their regulation by cytokines (22) . Although the promoters of these genes are homologous, it has been noted that the KB element differs between HLA-A and -B and HLA-C (51) and that the ICS element differs between HLA-A and HLA-B and -C (23) . The difference in the KB elements has been suggested to mediate differential regulation by TNF (51) , and the difference in the ICS has been reported to be the basis of differential regulation by IFNs (23 S1 nuclease protection. Construction of the probes for -y-actin and the conserved third domain of HLA class I heavy chain has been described elsewhere (29) . Cytoplasmic RNA was prepared by Nonidet P-40 lysis and phenol extraction (20) . RNA (5 ,ug) was hybridized overnight to continuously labeled, single-stranded probes in 50% formamide at 43°C and digested with S1 nuclease (350 U/ml; Bethesda Research Laboratories, Gaithersburg, Md.), and the products were separated on a denaturing polyacrylamide gel. The gel was dried and exposed to film to produce an autoradiograph, which was quantitated by densitometry (Molecular Dynamics, Sunnyvale, Calif.). For quantitation, the specific value of the HLA class I band was determined by subtracting the background counts obtained from an area of equal size immediately above the class I band, and this specific value was divided by the specific value from the -y-actin band to correct for the minor loading differences.
Reporter gene construction. The promoter of the HLA-B7 gene (gift of T. Spies, Harvard University) was PCR subcloned into EcoRl-and SmaI-cut pUC19 with a 5' primer that includes the endogenous EcoRI site at -670 bp (5'GGCTGCAGAATTCTAATCATTCAGGGA) and a 3' primer that starts one nucleotide 5' of the translation initiation codon (5'CTCGGCGTCTGAGGAGA) (49) . Deletion mutants were made by the appropriate restriction enzyme digestions, Klenow filling, and ligation or by PCR between the M13/pUC sequencing primer and the following 5' primers: A>, 5'CGTIGGGGATTCCCCACTCC; ICS>, 5'CCTGAGTTrCAC'1TCTrC; H>, 5'GACTCCCAACT TGTGTC; KB/C>B7, 5'CGTTGAGGATTCTCCACTCC; and KB/B-ICS/A>B7, 5'CGTJGGGGATTCCCCACTCC CCTGAGTIC'TTTCl'C'CTCCC). Either promoter sequences were isolated in an NdeI-BamHI fragment of pUC19 and placed in front of a promoterless human growth hormone (hGH) reporter gene (pOGH; Nichols Institute, San Juan Capistrano, Calif.) or PCR-generated deletion fragments were cut with BamHI and ligated between a Klenowfilled HindIII site and the BamHl site of pOGH. Oligonucleotides corresponding to the HLA-B7 KB and ICS elements, as well as the spacing mutants listed, were synthesized (Operon, Alameda, Calif.), annealed, and ligated into a HincIT-digested H>B7.GH plasmid.
Transfection and hGH assay. HeLa cells were trypsinized, washed once in Hanks' buffered salt solution, and suspended in ice-cold electroporation buffer (20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [HEPES; pH 7.05], 137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 6 mM dextrose [8] ) at approximately 107 cells per ml. Prior to transfection, the PCR-generated reporter gene constructs were digested with HindIII and EcoRI to separate the promoter-reporter gene fusion from the plasmid backbone.
A small portion of the restriction-cut plasmids was analyzed on an agarose gel to confirm digestion and DNA concentration. Cell aliquots (0.4 ml) were mixed with 15 ,ug of reporter gene DNA and 5 ,ug of luciferase expression DNA (pGL2CON; Promega, Madison, Wis.) to control for transfection efficiency, placed in chilled electroporation cuvettes (0.2-cm gap; Bio-Rad, Melville, N.Y.), and electroporated at 750 V/cm and 960 ,F (time constants ranged from 9 to 10 ms). Electroporated cells were mixed with medium (Dulbecco modified Eagle medium, 10% fetal calf serum, 1 mM glutamine) containing penicillin and streptomycin and divided into four wells of a 24-well plate. After 24 h, the medium was aspirated and replaced with cytokine-containing medium. Culture medium was harvested 18 to 20 h later, and 100-,ul samples were assayed for hGH, using a solidphase sandwich radioimmunoassay as described by the manufacturer (Nichols Institute). Radioactivity was measured in a gamma counter (model 5500B; Beckman, Palo Alto, Calif.). Cell lysates were assayed for luciferase by using a kit as described by the manufacturer (Promega) and read on a luminometer (Berthold LB9501).
Nuclear extracts and electrophoretic mobility shift assay (EMSA). Nuclear proteins were extracted from approximately 5 x 106 HeLa cells by a miniprep modification of the procedure of Dignam et al. (13) Samples (5 jil) were then withdrawn and electrophoresed at 15 V/cm through a native 4% polyacrylamide-2% glycerol gel (prerun for 30 min) in 0.25x Tris-borate-EDTA) electrode buffer at 20°C until the xylene cyanol tracking dye had migrated -11 cm. The gel was dried and exposed to film or to storage phosphor screen for quantitation on a PhosphorImager (Molecular Dynamics).
Immunochemical identification of nuclear factors (antibody EMSA). Nuclear extracts were prepared as described above.
Extracted protein (6 jig) was combined with supershift buffer (100 mM KCl, 25 (12) . This mutant retained a synergistic response although expression was substantially reduced compared with that of AET, suggesting that the enhancer B element is involved with increasing the efficiency of transcription initiation and not with mediating synergy directly. This role for the B element has also been suggested from studies of the murine class I promoter H-2Ld (14) . These Three different complexes are formed between the ICS esponses that were indeprobe and nuclear proteins extracted from the nuclei of t, perhaps resulting from HeLa cells treated with IFN--y for 4 h (Fig. 4b, lane 4) . but not KB oligonucleotides (Fig. 4b, lanes 7 and 6) . A probe containing both the KB and ICS sequences (KB-ICS) was tested in an EMSA with nuclear extracts from untreated cells and cells treated with TNF, IFN--y, or both TNF and IFN--y (Fig. 5a ). TNF (Fig. 5b, lanes 5 and 6) ".. factor. HeLa cells were left untreated or treated with TNF (100 U/ml), IFN-y (250 U/ml), or both TNF and IFN-y for 4 h, and then nuclear extracts were prepared. Competitor DNA was added at 100-fold excess over labeled (probe) DNA. proteins from TNF-and IFN-cotreated cells with the normal spacing, the A5 and A10 probes (lanes 5, 10, and 15, respectively), compared with treatments with either cytokine alone.
IFN-y-induced ISGF2 binds to the ICS, and a TNF-activated p50-and p65-containing NF-cB binds to the KB element. The identities of the nuclear factors binding to the HLA class I KB and ICS elements were determined by supershift antibody EMSA. TNF-activated nuclear factors bound to the KB probe are recognized by antibodies specific for the p5O and p65 subunits of NF-KB (Fig. 6a) . The IFN-y-induced nuclear factor bound to the ICS probe is recognized by antibodies in the ISGF2-specific antiserum but not by the anti-p50 antiserum (Fig. 6b) . These results suggest that the IFN-y-induced nuclear factor is ISGF2 and that the TNFactivated nuclear factors contain the p50 and p65 subunits of NF-KB.
Functional differences are detected in the KB and ICS elements of the HLA-A, -B, and -C promoters. Although the HLA-A and -B and HLA-C promoters are very similar in the region from the KB site through the variant TATA (TCTA) box (Fig. 7a) (Fig. 7d, lanes 4 and 5 versus lane 6) . The relative strength of ICS/B versus ICS/A binding is observed at 1:100 and 1:500 probe/competitor ratios and is even more dramatic in EMSA at higher ionic strength (data not shown).
DISCUSSION
The term synergy has been widely used to describe greater than additive interactions between cytokines. The molecular Unlabeled competitor oligonucleotides were added at 100-fold excess over the labeled probe, the incubation was continued for 20 min, and samples were separated on a nondenaturing polyacrylamide gel.
lating population into sites of immune reactions in the periphery. Cultured human endothelial cells are only inefficiently transfected, however; therefore, to pursue an investigation of the class I promoter elements mediating a synergistic cytokine response, HeLa cells were tested to see whether the class I genes of this efficiently transfected cell respond synergistically to TNF and IFNs. Flow cytometric analysis of HeLa cells showed that TNF, IFN-0, and IFN-y each increase HLA class I surface expression and that a greater than additive induction is observed between TNF and either type of IFN (not shown). Analysis of HLA heavy-chain mRNA expression by S1 nuclease protection revealed a striking synergy between TNF and IFNs, particularly at early times (Fig. 1) . For this reason, we chose to use HeLa cells to study the molecular basis of synergy. However, it should be noted that HeLa cells are not perfect models for endothelial cells. For example, although the HLA light chain (02-microglobulin) mRNA is also induced in HeLa cells by TNF or IFNs, synergistic induction of lightchain mRNA is not observed (not shown), in contrast to endothelial cells, in which the rate of light-chain gene transcription and mRNA levels are both synergistically increased by combined treatment with TNF and IFN--y (29) .
In this study of the class I promoter elements mediating synergistic induction by TNF and IFNs, HeLa cells were transfected with a reporter gene under control of the HLA-B7 human MHC class I gene promoter. Strong synergy was observed in a construct containing 680 bp of the promoter, and 5' and internal deletions mapped the elements mediating TNF and IFN responses, as well as synergy between these cytokines, to a 150-bp fragment that contains a KB element (previously termed enhancer A [31] ), which conforms to the NF-KB consensus binding sequence, and an ICS (Fig. 2a) . Additional, PCR-generated 5' deletion mu- VOL. 14, 1994 on December 21, 2017 by guest http://mcb.asm.org/ Downloaded from tants within this region demonstrated that the KB element is the principal mediator of the TNF response, that the ICS is the principal mediator of the IFN response, and that both elements are required for synergistic induction of the HLA-B7 promoter ( Fig. 2b and 3) . Repeated canonical and degenerate KB elements contained in the murine H-2K" class I gene promoter have been reported to be required for the response of this gene to TNF (28) . However, no repeated KB elements are present in the HLA-B7 promoter. Furthermore, although we have seen that multimers of the KB element from HLA-B7 confer upon heterologous promoters a stronger response to TNF than does a single element (not shown), the results reported here suggest that in the context of the HLA-B7 promoter, a single KB element is necessary and sufficient for response to TNF.
Deletion analysis of the murine class I H-2Kb promoter fragments suggested that both the KB element and the ICS are required for conferral of IFN responsiveness upon the heterologous conalbumin or Q10 promoter in transfected HeLa cells (27) . In contrast, the studies presented here clearly demonstrate that the ICS but not the KB element is required for response to IFN in the context of the homologous HLA-B7 promoter in transfected HeLa cells (Fig. 2b  and 3 ).
The interaction of DNA-binding proteins with each other and with the transcription initiation complex is thought to involve the looping out of the intervening DNA, thereby bringing the factors together and permitting protein-protein contacts (40) . These contacts are facilitated when the proteins bind on the same side of the DNA helix. Experimental support for this hypothesis derives in part from the demonstration of a fine spacing effect on interactions between some cis-acting DNA elements. For example, in bacterial operons, the interaction between A repressor proteins is optimal when their binding sites are separated by an integral number of -10-bp units, i.e., multiples of turns around the DNA helix (25) . In addition, the normal spacing of several cis-acting elements in the avian skeletal a-actin promoter is not optimal for constitutive expression, suggesting that induction occurs by tissue-specific protein-induced torsional deformation that brings these elements into alignment (7). However, exceptions have also been reported. The interaction of two closely spaced, inducible enhancers in the human proenkephalin gene has been carefully investigated (9) , and it was found that the effects of partial-or full-turn-of-the-helix deletions were measurable but not dramatic. Similarly, no clearly interpretable spacing effect was shown for interactions between the steroid receptor binding site and a second cisacting element (46) . The failure to demonstrate distance or phasing dependence of DNA-protein binding sites has been attributed to protein flexibility. To investigate the phasing dependence of cytokine synergy, the effect of altering the normal, approximately 10-bp spacing between the KB element and the ICS was tested. Essentially equivalent responses were obtained when the spacing between the KB element and the ICS was maintained or reduced by 5 or 10 bp, i.e. a half or a full turn of the DNA helix (Fig. 2b) , suggesting that positive interactions between these inducible enhancers and the transcription initiation complex do not strictly depend on their binding to a particular face of the DNA helix.
Protein factors (trans acting) that bind cis-acting DNA elements regulate transcription by interacting with the transcription initiation complex. Proteins isolated from the nuclei of TNF-or IFN--y-treated HeLa cells bind specifically to KB-or ICS-containing DNA probes, respectively, in EMSA ( Fig. 4a and b) . When tested with individual KB or ICS probes, nuclear factors from HeLa cells treated with both TNF and IFN--y are indistinguishable from those from singly TNF-or IFN-y-treated cells (Fig. 4) . Extracts from the nuclei of cells treated with both TNF and IFN--y bind to a KB-ICS probe to produce a complex of lower mobility than those produced by either cytokine alone. Nuclear factors from TNF-treated cells produce the same lower-mobility complex with a KB-ICS probe, albeit much more weakly, as do nuclear factors from cells treated with both TNF and IFN-,y, probably because TNF also weakly induces the ICS-binding activity (Fig. 4b) . Furthermore, proteins isolated from cells treated with each cytokine individually combine in vitro to form the same complexes with a KB-ICS probe as do proteins isolated from cells cotreated with TNF and IFN--y (Fig. Sb) . This observation suggests that synergy between TNF and IFN-y in the induction of HLA-B7 transcription results from the interactions of individually induced enhancer-binding proteins and not from the induction of a unique proteins in cotreated cells. A similar lower-mobility complex was observed when the extracts from TNF-and IFN--y-treated cells are allowed to bind to the 5-or 10-bp deletion mutants, although it is reduced in the 10-bp deletion (Fig. Sc) . The binding of TNF-or IFN-yinduced factors to the 10-bp deletion mutant is not reduced (Fig. Sc) , demonstrating that the binding sites for these factors are intact.
Two related regulatory factors have been shown to bind to the KB element of mouse and human class I MHC genes: NF-KB, which is a heterodimer of 50-kDa (p5O) and 65-kDa (p65) subunits, and KBF1, which is a p5O homodimer (3, 30) . The p65 subunit of NF-KB binds IKB and is the principal transcriptional activator component of the heterodimer (45) . KBF1 binds constitutively to two imperfect direct KB repeats in the mouse MHC class I gene H-2Kb, from which it is displaced by the binding of an NF-KB-like factor (28) . In some systems, p5O homodimers (KBF1) have been reported to be transcriptionally inactive and capable of suppressing p65-mediated transcriptional activation (45) . However, KBF1 has also been implicated in the constitutive expression of HLA class I genes (3) . A resolution of this apparent dilemma is suggested by a recent report demonstrating that transactivation by, but not the binding of, NF-KB is sensitive to seemingly minor sequence variations between the canonical KB and the MHC class I KB elements (38) . Similarly, KBF1 may bind to the MHC class I KB sequence in such a way as to promote constitutive transcription. Alternatively, because the antibody used here was raised and purified against the p50 nuclear localization signal peptide that is almost identical to that found in p5OB, the KB-binding complexes observed could contain either p5O, p5OB, or both. pSOB is a distinct gene product that can form homodimers, which can associate with Bcl-3 to form a transcriptional activator (4).
Several nuclear factors that mediate IFN-regulated gene expression have been reported. The antibody EMSA gels shown here suggest that the IFN--y-induced ICS-binding factor is ISGF2. ISGF2 (also known as IRF-1 and IBP-1 [39] ) binds to AAGTGA repeats (36) and to the complementary TTCACTT-containing ICS of H-2K" (2) . IRF-2 binds to the same sequence and acts as a repressor (24) , although an inducible, truncated form lacks repressor activity (37) . This sequence is found in the ICS element contained on the coding strand of the ICS in HLA-B and -C, and the TTCTTTTT-containing sequence of HLA-A also binds to ISGF2, although less strongly ( Fig. 7c and d) Type I IFN (IFN-a) rapidly activates the transcription factor ISGF3, which binds to a sequence termed the IFNstimulated response element, a portion of which is homologous to the ICS. It is possible that IFN-,B acts by inducing ISGF3. The ISGF3-ICS complex is reported to be unstable in the presence of higher salt concentrations (41) , which may account for our inability to detect this activity in the high-salt extracts used here. The data presented here are most consistent with the conclusion that IFN-y and IFN-, act by inducing different transcription factors that bind to the same cis-regulatory element. However, our results are not fully consistent with a role for ISGF3 as the mediator of IFN-,Binduced class I expression. Since it has been proposed that IFN-y increases one ISGF3 subunit (,y) and type I IFN activates the other (a), it might therefore be expected that type I and type II IFNs would synergize in their induction ISGF-3-regulated genes. As shown in Fig. 1 , this combination of IFNs produces at best an additive increase in HLA class I heavy-chain mRNA. Similar lack of IFN interaction was found in endothelial cells (29 The results presented here demonstrate the importance of the KB and ICS elements in the cytokine-regulated expression of HLA class I genes. These elements differ between HLA-A, -B, and -C (Fig. 7a) . The difference in the ICS between HLA-A and HLA-B and -C has been reported to be the basis of the difference in the response of these genes to IFNs (23) . However, IFN--y responsiveness is retained when two nucleotides of the HLA-B7 ICS element are changed to match an HLA-A ICS (Fig. 7b) . The fundamental difference between these studies is that the earlier study specifically changes the ICS of the HLA-A promoter to match the ICS of HLA-B, C, whereas the present study changes the ICS of HLA-B7 to match the ICS of HLA-A. Taken together, the results of these nearly reciprocal experiments suggest that additional sequences between the ICS and the transcription initiation site are important in the response of the HLA class I promoters to IFNs, a suggestion that has also arisen in the analysis of transgenic mice (6) . The difference in the KB elements between HLA-C and HLA-A and -B has been proposed to underlie the difference in their responses to TNF (51) . Indeed, we show here that the KB element of HLA-C (KB/C) is unresponsive to TNF alone or in combination with IFN-y (Fig. 7b) . The failure of the KB/C to mediate a TNF response correlates with the failure of KB/C to compete with KB/B for the binding of TNF-induced nuclear factors (Fig. 7c) . In contrast, ICS/A competes with ICS/B, albeit relatively less effectively than ICS/B, for the binding of IFN-y-induced nuclear factors (Fig. 7c) .
In summary, the synergistic interactions between TNF and IFNs as regulators of HLA class I transcription can be fully explained by the independent effects of these two classes of cytokines on the class I promoter. Our spacing experiments have not revealed direct molecular interactions between TNF-induced factors binding to the KB element and IFN-induced factors binding to the ICS element. However, our identification of the relevant cis elements and the cytokine-induced proteins that bind to them will allow this question to be more precisely addressed in the future.
